AB
GEVA

Amalgamated Bank’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Amalgamated Bank’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,333
Closed -$228K – 1378
2015
Q1 		$228K Buy
+2,333
New +$247K 0.03% 815
2014
Q3 		– Sell
-2,088
Closed -$219K – 878
2014
Q2 		$219K Buy
+2,088
New +$178K 0.03% 776

Amalgamated Bank's GEVA Position: Q2 2015 in Review

Amalgamated Bank sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 2,333 shares — an estimated $228K sold.

Amalgamated Bank first reported a position in GEVA in Q2 2014 and held it in 2 quarters. The position peaked at $228K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Amalgamated Bank reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Amalgamated Bank sold 2,333 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $228K.
  • Amalgamated Bank first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • Amalgamated Bank's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $228K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Amalgamated Bank's 13F filing for Q2 2015, filed 10 Jul 2015.